PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |